📉 Palantir (PLTR) — Why Is It Falling & What Should Investors Do?
Date: June 26, 2026
Ticker: PLTR:NASDAQ
Model: deepseek-chat
Tags:
URL: https://stocksfundamentals.online/pltr-why-falling-jun26.html
Current Snapshot
| Metric | Value |
|---|---|
| Current Price | ~$133 |
| YTD Performance | -32% |
| 52-Week Range | $122.68 – $207.52 |
| Market Cap | ~$319B |
| P/E (Trailing) | ~150x |
| Forward P/E | ~84x |
| Q1 Rev Growth | +85% YoY |
| US Commercial Growth | +133% YoY |
| FY2026 Guidance | $7.65B (+71%) |
| Consensus Target | ~$190 (+37%) |
| Analyst Consensus | Moderate Buy |
Why Is PLTR Falling?
1️⃣ Multiple Compression — The Reason
Entered 2026 at P/E ~155x and P/S ~62x. After doubling in 2025, the stock had zero margin for error. Market rotated from "growth at any price" to value. Even after -32% YTD, forward P/E is still ~84x.
2️⃣ "Buy the Rumor, Sell the News"
Q1 was a blowout ($1.633B, +85% YoY, largest-ever guidance raise) yet stock fell earnings day ($144 → $133). Everything was already priced in.
3️⃣ Sector Rotation
Broad rotation from AI darlings into value stocks. Fed rate hike fears (90% by Sep). AI capex fatigue. "SaaS-pocalypse" weighing on software.
4️⃣ Specific Headwinds
- 🇬🇧 UK NHS contract under review, £50M Met contract blocked
- 🇫🇷 France geopolitical concerns
- 🏛️ Competition from OpenAI/Anthropic
- 💼 Insider selling
- 🕊️ Iran ceasefire dampens defense urgency
Analyst Ratings
| Firm | Rating | Target | Date |
|---|---|---|---|
| Wolfe Research | Upgraded to Hold | No PT | Jun 16 |
| UBS | Buy | $180 | Jun 16 |
| Rosenblatt | Buy | $225 | Jun 5 |
| Wedbush | Outperform | $200+ | Jun 5 |
| HSBC | Hold | $151 | May 4 |
| Citigroup | Buy | $260 | Feb 3 |
| BofA | Buy | $255 | Nov '25 |
| Jefferies | Sell/Neutral | $60-$208 | 2025-26 |
Consensus: 2 Strong Buy, 17 Buy, 12 Hold, 3 Sell — Range: $60 to $260
Bear Case 🐻
- Valuation still extreme (Burry fair value ~$46)
- Cisco dot-com parallels (90% drawdown risk)
- Law of large numbers — 60% growth compounds unsustainably
- Competition from frontier AI labs
- International growth only 26% vs US 133%
- UK contract/London legal risks
Bull Case 🐂
- 85% revenue growth, 60%+ margins, Rule of 40 at 145
- US commercial at tipping point (133% growth)
- Record deal activity — 206 deals >$1M in Q1
- "Cannot meet demand" — CEO
- Defense super-cycle: Golden Dome, Maven, TITAN
- Google Cloud partnership opens distribution
- Vast TAM as enterprise AI OS
⚖️ THE VERDICT
For Existing Holders
Don't panic sell at 52-week lows. The business is genuinely stronger than at $76. But:
- Stock could fall another 20-30% on multiple compression
- Cost basis matters: bought at $80-100? Fine. Bought at $180-200? Long horizon needed
- 3-5 year hold with AI defense thesis is rational
- Consider position sizing — trim if >20% of portfolio
For New Investors
Wait, don't rush. DCA in.
- Forward P/E of 84x is better than 220x but still expensive
- Consider SIP: buy 1/4 now, 1/4 at $110, 1/4 at $95, 1/4 at $80
- Wait for Q2 earnings (Aug 3) as catalyst
- 3-5% of portfolio max given volatility
- Risk/reward better at $133 than $207, but not a no-brainer
Key Catalysts to Watch
- Q2 2026 Earnings (Aug 3) — guided $1.797B-$1.801B
- Golden Dome contract award — $1T+ opportunity
- Google Cloud partnership scale-up
- UK NHS contract decision
- Fed rate decision (Sep)
- SpaceX IPO sentiment halo
Valuation Scenarios
| Scenario | P/E Multiple | Fair Value | vs $133 |
|---|---|---|---|
| Bull (Street) | ~65x 2027E | $200-260 | +50% to +95% |
| Base | ~50x 2027E | $140-160 | +5% to +20% |
| Bear (DCF) | ~35x 2027E | $96-122 | -8% to -28% |
| Burry Floor | ~20x 2027E | $46-70 | -47% to -65% |
Comparison: Jun 18 → Jun 26
| Metric | Jun 18 ($126.85) | Jun 26 ($107.27) | Change |
|---|---|---|---|
| Price | $126.85 | $107.27 | -15.4% in 8 days |
| YTD | -18% | -40.8% | More than doubled |
| 52W Low | $122.68 | $106.38 | Old support broke |
| RSI (14) | 39.74 | 27.37 | Deeper oversold |
| MACD | -2.88 | -6.64 | Momentum accelerating down |
| Price vs SMA(200) | 21% below | 33% below | Deviation widened massively |
| Volume | Normal | 61.84M (spike) | Panic selling |
| Fresh Triggers | — | Zurich court loss | New legal overhang |
Key takeaway: Every single metric deteriorated. The $122.68 and $118.66 supports we flagged — both broke. At 33% below 200-day SMA, historically signals either sharp snap-back or deeper capitulation. Fundamentals unchanged, market's willingness to pay collapsed.
TradingView Technical Data (As of Jun 25 Close)
Summary: STRONG SELL — Oscillators: Sell 2, Neutral 9, Buy 0 | MAs: Sell 14, Neutral 1, Buy 0
Oscillators
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 27.37 | Neutral (deeply oversold) |
| Stochastic %K | 2.55 | Neutral (near zero) |
| CCI (20) | -174.58 | Neutral |
| ADX (14) | 21.17 | Neutral |
| Awesome Osc | -15.47 | Neutral |
| Momentum (10) | -22.94 | Sell |
| MACD Level | -6.64 | Sell |
| Stoch RSI Fast | -0.00 | Neutral |
| Williams %R | -97.47 | Neutral (oversold) |
| Bull Bear Power | -30.61 | Neutral |
| Ultimate Osc | 30.96 | Neutral |
Moving Averages — ALL Sell
| MA | Value | Distance |
|---|---|---|
| EMA(10) | $122.11 | -12% |
| SMA(10) | $124.31 | -14% |
| EMA(20) | $128.36 | -16% |
| SMA(20) | $133.70 | -20% |
| EMA(50) | $135.49 | -21% |
| SMA(100) | $140.38 | -24% |
| EMA(200) | $144.85 | -26% |
| SMA(200) | $159.09 | -33% |
Pivot Levels (Classic)
- R3: $205.75 | R2: $176.72 | R1: $166.63
- Pivot: $147.69 | S1: $137.60
- S2: $118.66 (broken) | S3: $89.63 (next target)
Technical Verdict
- Short-term (1-4 weeks): Bearish. Trend is decisively down. All MAs sell. First support is psychological $100, then $89.63 (S3).
- Medium-term (1-3 months): Mixed. Extreme oversold readings (RSI 27, Stoch 2.5) suggest mean-reversion bounce is statistically likely. Bounce to $120-130 would be natural, but that zone is now resistance.
- Catalysts needed: Q2 earnings (Aug 3), Golden Dome award, or Fed/macro catalyst.
Updated Verdict (Jun 26)
The gap between price and fundamentals has never been wider. At $107 vs ~$190 analyst consensus, the implied upside is 77%. But technicals are screaming bearish.
For Existing Holders
- At $107, we're down significantly from even the Jun 18 level ($126.85)
- If you bought at $80-100, you're still up — don't panic
- The stock could test $90-100 before a bounce — be prepared mentally
- Position sizing is everything — if this is stressful, trim to sleep-well level
- The business hasn't changed — 85% growth is still there
For New Buyers
- DCA is your best friend. At $107 vs $133 (what we flagged earlier), entry is 20% better already
- SIP plan update: buy 1/4 now, 1/4 at $95, 1/4 at $80, 1/4 at $70
- Or wait for a bounce confirmation above $120 (reclaim of old support as new resistance)
- The risk/reward at $107 is genuinely better than at $207 or even $133
- But chasing a falling knife is dangerous — let the stock prove it can hold $100 first
Not investment advice. I hold PLTR in my portfolio. Do your own research.